Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1996 1
1997 1
1998 1
2001 1
2002 3
2005 1
2006 2
2007 2
2008 3
2009 2
2010 2
2011 3
2012 1
2013 3
2014 6
2015 11
2016 4
2017 7
2018 10
2019 10
2020 13
2021 14
2022 10
2023 22
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.
Blankestijn PJ, Fischer KI, Barth C, Cromm K, Canaud B, Davenport A, Grobbee DE, Hegbrant J, Roes KC, Rose M, Strippoli GF, Vernooij RW, Woodward M, de Wit GA de, Bots ML. Blankestijn PJ, et al. BMJ Open. 2020 Feb 5;10(2):e033228. doi: 10.1136/bmjopen-2019-033228. BMJ Open. 2020. PMID: 32029487 Free PMC article. Clinical Trial.
The comparison of high-dose HDF with high-flux HD (CONVINCE) study will assess the benefits and harms of high-dose HDF versus a conventional high-flux HD in adults with ESKD. ...ETHICS AND DISSEMINATION: The CONVINCE study will address the question of benefits and harms …
The comparison of high-dose HDF with high-flux HD (CONVINCE) study will assess the benefits and harms of high-dose HDF versus a conve …
Antibiotics for acute otitis media in children.
Venekamp RP, Sanders SL, Glasziou PP, Del Mar CB, Rovers MM. Venekamp RP, et al. Cochrane Database Syst Rev. 2015 Jun 23;2015(6):CD000219. doi: 10.1002/14651858.CD000219.pub4. Cochrane Database Syst Rev. 2015. PMID: 26099233 Free PMC article. Updated. Review.
Adverse events (such as vomiting, diarrhoea or rash) occurred more often in children taking antibiotics (RR 1.38, 95% CI 1.19 to 1.59; number needed to treat for an additional harmful outcome (NNTH) 14). Funnel plots do not suggest publication bias. ...The benefits of anti …
Adverse events (such as vomiting, diarrhoea or rash) occurred more often in children taking antibiotics (RR 1.38, 95% CI 1.19 to 1.59; numbe …
New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective.
Allegranzi B, Bischoff P, de Jonge S, Kubilay NZ, Zayed B, Gomes SM, Abbas M, Atema JJ, Gans S, van Rijen M, Boermeester MA, Egger M, Kluytmans J, Pittet D, Solomkin JS; WHO Guidelines Development Group. Allegranzi B, et al. Lancet Infect Dis. 2016 Dec;16(12):e276-e287. doi: 10.1016/S1473-3099(16)30398-X. Epub 2016 Nov 2. Lancet Infect Dis. 2016. PMID: 27816413
The guidelines take into account the balance between benefits and harms, the evidence quality, cost and resource use implications, and patient values and preferences. ...
The guidelines take into account the balance between benefits and harms, the evidence quality, cost and resource use implications, an …
Drug treatments for covid-19: living systematic review and network meta-analysis.
Siemieniuk RA, Bartoszko JJ, Zeraatkar D, Kum E, Qasim A, Martinez JPD, Izcovich A, Lamontagne F, Han MA, Agarwal A, Agoritsas T, Azab M, Bravo G, Chu DK, Couban R, Devji T, Escamilla Z, Foroutan F, Gao Y, Ge L, Ghadimi M, Heels-Ansdell D, Honarmand K, Hou L, Ibrahim Q, Khamis A, Lam B, Mansilla C, Loeb M, Miroshnychenko A, Marcucci M, McLeod SL, Motaghi S, Murthy S, Mustafa RA, Pardo-Hernandez H, Rada G, Rizwan Y, Saadat P, Switzer C, Thabane L, Tomlinson G, Vandvik PO, Vernooij RW, Viteri-García A, Wang Y, Yao L, Zhao Y, Guyatt GH, Brignardello-Petersen R. Siemieniuk RA, et al. BMJ. 2020 Jul 30;370:m2980. doi: 10.1136/bmj.m2980. BMJ. 2020. PMID: 32732190 Free PMC article. Updated.
For each outcome, interventions were classified in groups from the most to the least beneficial or harmful following GRADE guidance. RESULTS: 463 trials enrolling 166 581 patients were included; 267 (57.7%) trials and 89 814 (53.9%) patients are new from the previous itera …
For each outcome, interventions were classified in groups from the most to the least beneficial or harmful following GRADE guidance. …
Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial.
Butler CC, van der Velden AW, Bongard E, Saville BR, Holmes J, Coenen S, Cook J, Francis NA, Lewis RJ, Godycki-Cwirko M, Llor C, Chlabicz S, Lionis C, Seifert B, Sundvall PD, Colliers A, Aabenhus R, Bjerrum L, Jonassen Harbin N, Lindbæk M, Glinz D, Bucher HC, Kovács B, Radzeviciene Jurgute R, Touboul Lundgren P, Little P, Murphy AW, De Sutter A, Openshaw P, de Jong MD, Connor JT, Matheeussen V, Ieven M, Goossens H, Verheij TJ. Butler CC, et al. Lancet. 2020 Jan 4;395(10217):42-52. doi: 10.1016/S0140-6736(19)32982-4. Epub 2019 Dec 12. Lancet. 2020. PMID: 31839279 Clinical Trial.
The estimated absolute mean benefit from oseltamivir was 1.02 days (95% [BCrI] 0.74-1.31) overall, and in the prespecified subgroups, ranged from 0.70 (95% BCrI 0.30-1.20) in patients younger than 12 years, with less severe symptoms, no comorbidities, and shorter previous illness …
The estimated absolute mean benefit from oseltamivir was 1.02 days (95% [BCrI] 0.74-1.31) overall, and in the prespecified subgroups, ranged …
TGFβ-Neurotrophin Interactions in Heart, Retina, and Brain.
Schlecht A, Vallon M, Wagner N, Ergün S, Braunger BM. Schlecht A, et al. Biomolecules. 2021 Sep 14;11(9):1360. doi: 10.3390/biom11091360. Biomolecules. 2021. PMID: 34572573 Free PMC article. Review.
As there is evidence that TGFbeta signaling has the potential to regulate expression of neurotrophins, it is tempting to speculate, and is discussed here, that cross-talk between TGFbeta and neurotrophin signaling protects cells from harmful and/or damaging events in the h …
As there is evidence that TGFbeta signaling has the potential to regulate expression of neurotrophins, it is tempting to speculate, and is d …
Infrasound a new weapon in cancer therapy?
Vahl JM, von Witzleben A, Reiter R, Theodoraki MN, Wigand M, Hoffmann TK, Goldberg-Bockhorn E. Vahl JM, et al. Explore (NY). 2022 May-Jun;18(3):366-370. doi: 10.1016/j.explore.2021.03.001. Epub 2021 Mar 9. Explore (NY). 2022. PMID: 33745848 Review.
BACKGROUND: Researchers take different positions when describing the effects of infrasound on the human body. Although several studies investigated the likely harmful effects of infrasound exposure from wind turbines a significant connection has not been found yet. ...
BACKGROUND: Researchers take different positions when describing the effects of infrasound on the human body. Although several studies inves …
Antioxidants for adults with chronic kidney disease.
Colombijn JM, Hooft L, Jun M, Webster AC, Bots ML, Verhaar MC, Vernooij RW. Colombijn JM, et al. Cochrane Database Syst Rev. 2023 Nov 2;11(11):CD008176. doi: 10.1002/14651858.CD008176.pub3. Cochrane Database Syst Rev. 2023. PMID: 37916745 Review.
This is an update of a Cochrane review first published in 2012. OBJECTIVES: To examine the benefits and harms of antioxidant therapy on death and cardiovascular and kidney endpoints in adults with CKD stages 3 to 5, patients undergoing dialysis, and kidney transplant recip …
This is an update of a Cochrane review first published in 2012. OBJECTIVES: To examine the benefits and harms of antioxidant therapy …
Antibiotics for otitis media with effusion (OME) in children.
Mulvaney CA, Galbraith K, Webster KE, Rana M, Connolly R, Marom T, Daniel M, Venekamp RP, Schilder AG, MacKeith S. Mulvaney CA, et al. Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD015254. doi: 10.1002/14651858.CD015254.pub2. Cochrane Database Syst Rev. 2023. PMID: 37870130 Review.
Antibiotics are sometimes used to treat any bacteria present in the effusion, or associated biofilms. OBJECTIVES: To assess the effects (benefits and harms) of oral antibiotics for otitis media with effusion (OME) in children. ...The long-term effects of antibiotics are un …
Antibiotics are sometimes used to treat any bacteria present in the effusion, or associated biofilms. OBJECTIVES: To assess the effects (ben …
Antibiotics for acute otitis media in children.
Venekamp RP, Sanders SL, Glasziou PP, Rovers MM. Venekamp RP, et al. Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD000219. doi: 10.1002/14651858.CD000219.pub5. Cochrane Database Syst Rev. 2023. PMID: 37965923 Review.
Antibiotics increase the risk of adverse events such as vomiting, diarrhoea or rash (RR 1.38, 95% CI 1.16 to 1.63; number needed to treat for an additional harmful outcome (NNTH) 14; 8 trials, 2107 children; high-certainty evidence). ...The benefits of antibiotics must be …
Antibiotics increase the risk of adverse events such as vomiting, diarrhoea or rash (RR 1.38, 95% CI 1.16 to 1.63; number needed to treat fo …
125 results